Hermans Sabine M, Zinyakatira Nesbert, Caldwell Judy, Cobelens Frank G J, Boulle Andrew, Wood Robin
Amsterdam UMC, University of Amsterdam, Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Clin Infect Dis. 2021 Jun 1;72(11):1919-1926. doi: 10.1093/cid/ciaa470.
Retreatment tuberculosis (TB) disease is common in high-prevalence settings. The risk of repeated episodes of recurrent TB is unknown. We calculated the rate of recurrent TB per subsequent episode by matching individual treatment episodes over a period of 13 years.
All recorded TB episodes in Cape Town between 2003 and 2016 were matched by probabilistic linkage of personal identifiers. Among individuals with a first episode notified in Cape Town and who completed their prior treatment successfully we estimated the recurrence rate stratified by subsequent episode and HIV status. We adjusted person-time to background mortality by age, sex, and HIV status.
A total of 292 915 TB episodes among 263 848 individuals were included. The rate of recurrent TB was 16.4 per 1000 person-years (95% CI, 16.2-16.6), and increased per subsequent episode (8.4-fold increase, from 14.6 to 122.7 per 1000 from episode 2 to 6, respectively). These increases were similar stratified by HIV status. Rates among HIV positives were higher than among HIV negatives for episodes 2 and 3 (2- and 1.5-fold higher, respectively), and the same thereafter.
TB recurrence rates were high and increased per subsequent episode, independent of HIV status. This suggests that HIV infection is insufficient to explain the high burden of recurrence; it is more likely due to a high annual risk of infection combined with an increased risk of infection or progression to disease associated with a previous TB episode. The very high recurrence rates would justify increased TB surveillance of patients with >1 episode.
复治结核病在高流行地区很常见。复发性结核病反复发作的风险尚不清楚。我们通过匹配13年期间的个体治疗发作情况,计算了每后续发作的复发性结核病发生率。
通过个人标识符的概率链接,对2003年至2016年开普敦所有记录的结核病发作情况进行匹配。在开普敦首次发作并成功完成先前治疗的个体中,我们按后续发作情况和艾滋病毒感染状况分层估计复发率。我们根据年龄、性别和艾滋病毒感染状况对人时进行背景死亡率调整。
共纳入263848名个体的292915次结核病发作情况。复发性结核病的发生率为每1000人年16.4例(95%可信区间,16.2 - 16.6),并且随着每后续发作而增加(增加8.4倍,从第2次发作到第6次发作,分别从每1000人年14.6例增加到122.7例)。按艾滋病毒感染状况分层,这些增加情况相似。在第2次和第3次发作时,艾滋病毒阳性者的发生率高于艾滋病毒阴性者(分别高出2倍和1.5倍),此后相同。
结核病复发率很高,并且随着每后续发作而增加,与艾滋病毒感染状况无关。这表明艾滋病毒感染不足以解释高复发负担;更可能是由于每年的高感染风险,以及与先前结核病发作相关的感染或疾病进展风险增加。非常高的复发率表明对有>1次发作的患者加强结核病监测是合理的。